SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Tzioufas T, Youinou P, Moutsopoulos HM. Sjögren's syndrome. In: MaddisonPJ, IsenbergDA, WooP, GlassDN, editors. Oxford textbook of rheumatology. 2nd ed. Oxford: Oxford Medical Publications; 1997. p. 130117.
  • 2
    Jonsson R, Klareskog L, Backman K, Tarkowski A. Expression of HLA-D-locus (DP, DQ, DR)-coded antigens, beta 2-microglobulin, and the interleukin 2 receptor in Sjogren's syndrome. Clin Immunol Immunopathol 1987; 45: 23543.
  • 3
    Manoussakis MN, Dimitriou ID, Kapsogeorgou EK, Xanthou G, Paikos S, Polihronis M, et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 1999; 42: 22939.
  • 4
    Tsunawaki S, Nakamura S, Ohyama Y, Sasaki M, Ikebe-Hiroki A, Hiraki A, et al. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjögren's syndrome. J Rheumatol 2002; 29: 188496.
  • 5
    Chused TM, Kassan SS, Opelz G, Moutsopoulos HM, Terasaki PI. Sjögren's syndrome association with HLA-Dw3. N Engl J Med 1977; 296: 8957.
  • 6
    Fye KH, Terasaki PI, Michalski JP, Daniels TE, Opelz G, Talal N. Relationship of HLA-Dw3 and HLA-B8 to Sjögren's syndrome. Arthritis Rheum 1978; 21: 33742.
  • 7
    Kang HI, Fei HM, Saito I, Sawada S, Chen Si, Yi D, et al. Comparison of HLA class II genes in Caucasoid, Chinese and Japanese patients with primary Sjögren's syndrome. J Immunol 1993; 150: 361523.
  • 8
    Fei HM, Kang H, Scharf S, Erlich H, Peebles C, Fox R. Specific HLA-DQA and HLA-DRB1 alleles confer susceptibility to Sjögren's syndrome and autoantibody production. J Clin Lab Anal 1991; 5: 38291.
  • 9
    Harley JB, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986; 232: 11457.
  • 10
    Rischmueller M, Lester S, Chen Z, Champion G, van den Berg R, Beer R, et al. HLA class II phenotype controls diversification of the autoantibody response in primary Sjögren's syndrome. Clin Exp Immunol 1998; 111: 36571.
  • 11
    Bolstad AI, Wassmuth R, Haga HJ, Jonsson R. HLA markers and clinical characteristics in Caucasians with primary Sjögren's syndrome. J Rheumatol 2001; 28: 155462.
  • 12
    Tzioufas AG, Wassmuth R, Dafni UG, Guialis A, Haga HJ, Isenberg DA, et al. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study. Ann Rheum Dis 2002; 61: 398404.
  • 13
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 14
    Loiseau P, Lepage V, Djelal F, Busson M, Tamouza R, Raffoux C, et al. HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome. Hum Immunol 2001; 62: 72531.
  • 15
    Keech C, McCluskey J, Gordon T. Transfection and overexpression of the human 60 kDA Ro/SS-A autoantigen in Hep-2 cells. Clin Immunol Immunopathol 1994; 73: 14651.
  • 16
    Yasuda N, Kimura M. A gene country method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann Hum Genet 1968; 31: 40920.
  • 17
    Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956; 20: 30914.
  • 18
    Manthorpe R, Morling N, Platz P, Ryder LP, Svejgaard A, Thomsen M. HLA-D antigen frequencies in Sjögren's syndrome: differences between the primary and secondary form. Scand J Rheumatol 1981; 10: 1248.
  • 19
    Papasteriades CA, Skopouli FN, Drosos AA, Andonopoulos AP, Moutsopoulos HM. HLA-alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun 1988; 1: 8590.
  • 20
    Guggenbuhl P, Jean S, Jego P, Grosbois B, Chales G, Semana G, et al. Primary Sjögren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. J Rheumatol 1998; 25: 9005.
  • 21
    Davies ML, Taylor EJ, Gordon C, Young SP, Welsh K, Bunce M, et al. Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum 2002; 46: 20914.
  • 22
    Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol 2002; 168: 587684.
  • 23
    Painsansinsup T, Vallejo AN, Luthra H, David CS. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J Immunol 2001; 167: 408390.
  • 24
    Reveille JD, Macleod MJ, Whittington K, Arnett FC. Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol 1991; 146: 38716.
  • 25
    Scofield RH, Frank MB, Neas BR, Horowitz RM, Hardgrave KL, Fujisaku A, et al. Cooperative association of T cell beta receptor and HLA-DQ alleles in the production of anti-Ro in systemic lupus erythematosus. Clin Immunol Immunopathol 1994; 72: 33541.
  • 26
    Tzioufas AG, Moutsopoulos HM. Epitopes and complementary epitopes of autoantigens: candidate probes to study and modulate the autoimmune response. Clin Exp Rheumatol 2002; 20: 28991.